Developmental Dysphasia Familial
Symptoms, Doctors, Treatments, Advances & More

Developmental Dysphasia Familial Overview

Save information for later
Sign Up

Learn About Developmental Dysphasia Familial

What is the definition of Developmental Dysphasia Familial?
Developmental dysphasia is a language disorder that develops in children. The disorder typically involves difficulties speaking and understanding spoken words. The symptoms cannot be attributed to sensorimotor, intellectual deficits, autism spectrum, or other developmental impairments. Likewise it does not occur as the consequence of an evident brain lesion or as a result of the child's social environment. Familial cases of developmental dyphasia have been described. In these families, the condition is inherited in an autosomal dominant fashion.
What are the alternative names for Developmental Dysphasia Familial?
  • Developmental dysphasia familial
  • Developmental language disorder
  • Specific language impairment
Who are the top Developmental Dysphasia Familial Local Doctors?
Elite in Developmental Dysphasia Familial
Elite in Developmental Dysphasia Familial
Referral may be required

Mayo Clinic-Rochester

5716 Cleveland St Ste 200, 
Virginia Beach, VA 
507-284-2511
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Knopman is a Neurologist practicing medicine in Virginia Beach, Virginia. Dr. Knopman is rated as an Elite provider by MediFind in the treatment of Developmental Dysphasia Familial. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Dementia, Alzheimer's Disease, Lewy Body Dementia (LBD), and Frontotemporal Dementia.

Elite in Developmental Dysphasia Familial
Elite in Developmental Dysphasia Familial
Referral may be required
94 Mallett Street, 
Sydney, NSW, AU 

Muireann Irish practices practicing medicine in Sydney, Australia. Ms. Irish is rated as an Elite expert by MediFind in the treatment of Developmental Dysphasia Familial. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Frontotemporal Dementia, Memory Loss, Developmental Dysphasia Familial, and Dementia.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Developmental Dysphasia Familial
Elite in Developmental Dysphasia Familial
Referral may be required
94 Mallett Street, 
Sydney, NSW, AU 

Olivier Piguet practices practicing medicine in Sydney, Australia. Mr. Piguet is rated as an Elite expert by MediFind in the treatment of Developmental Dysphasia Familial. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Frontotemporal Dementia, Dementia, Primary Progressive Aphasia, and Developmental Dysphasia Familial.

View All Doctors
What are the latest Developmental Dysphasia Familial Clinical Trials?
Phase II Clinical Trial of Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
Phase II Clinical Trial of Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
Enrollment Status: Recruiting
Publish Date: May 05, 2026
Intervention Type: Device
Study Phase: Phase 2

Summary: While many have strongly suggested that transcranial direct current stimulation (tDCS) may represent a beneficial intervention for patients with primary progressive aphasia (PPA), this promising technology has not yet been applied widely in clinical settings. This treatment gap is underscored by the absence of any neurally-focused standard-of-care treatments to mitigate the devastating impact of a...

Match to trials
Find the right clinical trials for you in under a minute
Get started
The Swedish BioFINDER 2 Study
The Swedish BioFINDER 2 Study
Enrollment Status: Recruiting
Publish Date: April 06, 2026
Intervention Type: Diagnostic test
Study Phase: Not Applicable

Summary: The Swedish BioFINDER 2 study is a new study that will launch in 2017 and extends the previous cohorts of BioFINDER 1 study (www.biofinder.se). BioFINDER 1 is used e.g. to characterize the role of beta-amyloid pathology in early diagnosis of Alzheimer's disease (AD) using amyloid-PET (18F-Flutemetamol) and Aβ analysis in cerebrospinal fluid samples. The BioFINDER 1 study has resulted in more than ...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center